Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04020471 · ClinicalTrials.gov registry record
How Variations in Pharmacogenomic Profiles Affect Pain and Narcotic Needs Following Total Knee Arthroplasty (TKA)
A clinical trial, sponsored by Endeavor Health.
- Completed
- Registry status
- 375
- Enrollment target
NCT04020471 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 375 participants.
The verdict
NCT04020471 has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- 375 participants
- Enrollment target
Study Summary
The purpose of the study is to gain a better understanding of how genetic variations can affect pain experience and the need and type of pain control medication after a total knee replacement.
Interventions
- OTHER Pain Scale/Medication Log
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2019-04-11 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04020471
The ClinicalTrials.gov registry entry for NCT04020471 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pain Scale/Medication Log is the first listed.
NCT04020471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04020471 about?
NCT04020471 is a clinical study titled "How Variations in Pharmacogenomic Profiles Affect Pain and Narcotic Needs Following Total Knee Arthroplasty (TKA)". The purpose of the study is to gain a better understanding of how genetic variations can affect pain experience and the need and type of pain control medication after a total knee replacement.
What is the current status of trial NCT04020471?
This trial is currently completed. The enrollment target is 375 participants. The study started on 2019-04-11. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04020471?
The interventions under investigation include: Pain Scale/Medication Log (OTHER).
Who is sponsoring clinical trial NCT04020471?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.